Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,320 | -28,962 | -19,445 | -19,127 | -14,400 |
| Depreciation Amortization | 595 | 252 | 256 | 822 | 1,003 |
| Accounts receivable | N/A | N/A | N/A | 34 | 40 |
| Accounts payable and accrued liabilities | -60 | 6,066 | 179 | -185 | -89 |
| Other Working Capital | 296 | 7,131 | 966 | 895 | 605 |
| Other Operating Activity | 1,601 | -5,754 | 1,936 | 3,596 | 2,473 |
| Operating Cash Flow | $-14,888 | $-21,267 | $-16,108 | $-13,965 | $-10,368 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 5,262 | -294 | 7,359 | N/A | N/A |
| PPE Investments | -18 | 47 | 3,814 | 204 | -22 |
| Purchase Of Investment | N/A | N/A | N/A | -22,535 | -18,613 |
| Sale Of Investment | N/A | N/A | N/A | 22,292 | 10,044 |
| Purchase Sale Intangibles | -538 | -585 | -185 | -592 | -573 |
| Other Investing Activity | -538 | -585 | -185 | -592 | -573 |
| Investing Cash Flow | $4,706 | $-832 | $10,988 | $-631 | $-9,164 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,500 | N/A | N/A | -122 | -355 |
| Debt Repayment | -251 | N/A | N/A | -4,732 | -4,330 |
| Common Stock Issued | 4,195 | 485 | 80 | 13,042 | 61,248 |
| Financing Cash Flow | $6,444 | $485 | $80 | $8,188 | $56,563 |
| Beginning Cash Position | 5,439 | 27,053 | 32,093 | 38,501 | 1,470 |
| End Cash Position | 1,701 | 5,439 | 27,053 | 32,093 | 38,501 |
| Net Cash Flow | $-3,738 | $-21,614 | $-5,040 | $-6,408 | $37,031 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,888 | -21,267 | -16,108 | -13,965 | -10,368 |
| Capital Expenditure | -18 | N/A | -86 | -41 | -22 |
| Free Cash Flow | -14,906 | -21,267 | -16,194 | -14,006 | -10,390 |